BCYC
Bicycle Therapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$3.72
+1.23%Next report
Analyst consensus
- Next report date
- Mar 16, 2027
- EPS estimate
- -$0.36
- Revenue estimate
- $1.1M
Latest reported
- Last report date
- Oct 29, 2026
- EPS actual
- -$0.15
- EPS estimate
- -$0.40
- Revenue actual
- $34.1M
- Revenue estimate
- $12.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +14.6%
- Revenue beats (12Q)
- 5
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 29, 2026 | -$0.40 | -$0.15 | Beat 62.41% | $34.1M |
| Jul 30, 2026 | -$0.56 | -$0.72 | Miss -27.59% | $629.0K |
| Apr 30, 2026 | -$0.60 | -$0.87 | Miss -45.27% | $887.0K |
| Mar 17, 2026 | -$0.94 | -$0.29 | Beat 69.06% | $48.0M |
| Oct 30, 2025 | -$1.09 | -$0.85 | Beat 22.02% | $11.7M |
| Aug 8, 2025 | -$0.95 | -$1.14 | Miss -20.00% | $2.9M |
| May 1, 2025 | -$0.86 | -$0.88 | Miss -2.33% | $10.0M |
| Feb 25, 2025 | -$0.85 | -$0.80 | Beat 5.88% | $3.7M |
| Oct 31, 2024 | -$0.78 | -$0.74 | Beat 5.13% | $2.7M |
| May 2, 2024 | -$1.26 | -$0.62 | Beat 50.79% | $19.5M |
| Feb 20, 2024 | -$1.23 | -$1.16 | Beat 5.69% | $5.3M |
| Nov 2, 2023 | -$1.06 | -$1.26 | Miss -18.87% | $5.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 16, 2027